Old Web
English
Sign In
Acemap
>
authorDetail
>
Veera Durga Sravanthi Panuganty
Veera Durga Sravanthi Panuganty
University of Western Ontario
Internal medicine
Medicine
Bisphosphonate therapy
postmenopausal women
Oncology
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events
2021
Clinical and Translational Science
Theodore J. Wigle
Brandi L. Povitz
Samantha Medwid
Wendy A. Teft
Robin M. Legan
John Lenehan
Stephanie Nevison
Veera Durga Sravanthi Panuganty
Denise Keller
Jaymie Mailloux
Victoria Siebring
Sisira Sarma
Yun-Hee Choi
Stephen Welch
Eric Winquist
Ute I. Schwarz
Richard B. Kim
Show All
Source
Cite
Save
Citations (2)
Usage and factors associated with adjuvant bisphosphonate therapy among postmenopausal women diagnosed with early-stage breast cancer.
2020
Journal of Clinical Oncology
Veera Durga Sravanthi Panuganty
Suganija Lakkunarajah
Sumugan Shanmuganathan
Morgan Black
Sharifa Nasreen
Igor Karp
Theodore A. Vandenberg
Jacques Raphael
Ricardo Fernandes
Phillip S. Blanchette
Show All
Source
Cite
Save
Citations (0)
1